Skip to main content
HR 2577 108th Congress House Foreign Trade and International Finance Commerce Congress Congressional investigations Congressional reporting requirements Drug industry Drugs Economics and Public Finance Health International Affairs Nontariff trade barriers Prescription pricing Price regulation Trade negotiations

To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.

Introduced: June 24, 2003 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 2, 2003
Referred to the Subcommittee on Trade.
Jul 1, 2003
Referred to the Subcommittee on Health.
Jun 24, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 24, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls.

What's happening now July 2, 2003

Referred to the Subcommittee on Trade.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Republican 1
R
Carter, John R.
Texas · Jul 9, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2577: To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.. 108th Congress. Open America. https://openamerica.io/bill/108-HR-2577/
MLA
"H.R. 2577: To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-2577/.
Bluebook (legal)
H.R. 2577, 108th Cong. (2026), https://openamerica.io/bill/108-HR-2577/.
Markdown link
[H.R. 2577: To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.](https://openamerica.io/bill/108-HR-2577/)
Report a problem